The complexity of the pharma supply chain

The life sciences, and in particular, the pharmaceutical supply chain, are far more complex than other products and industries. Pharmaceuticals and other medical products require unique compliance with FDA regulations and control. Ingredients are often scarce and difficult to procure.  Batch sizes can be in the millions all the way down to a batch size of one. Products often have to be temperature-controlled. This complexity sets this industry’s supply chains apart from most others and presents unique challenges for supply chain planning and operations.

The global nature of the pharma industry

The pharma supply chain is global. Building-block chemicals that are used for common off-the-shelf drugs such as acetaminophen and antibiotics are manufactured almost entirely in China and India. Other pharmaceuticals use unique and scarce ingredients that are sourced worldwide from plants and animals.

From individualized treatments to massive production of building-block chemicals, the manufacturing and shipment of these products to consumer markets is global, often originating in China and India and delivered worldwide. The risks of these long global supply chains and America’s complete dependence on imports for drugs such as antibiotics were fully exposed during the pandemic. This resulted in new regulations, massive funding opportunities for U.S. expansion, and the reshoring of some production.

Manufacturing, shipping, and logistics

In addition to long global supply chains, many pharma products incorporate unstable ingredients that must be kept in a temperature-controlled environment. This poses major challenges when sourcing active pharmaceutical ingredients, referred to as APIs, which are the core, biologically active components responsible for a drug’s intended therapeutic effect. They are part of the medicine that treats the disease, relieves pain, or prevents symptoms, and they are often rare and scarce.

Related podcast

 

Frictionless Supply Chain: The pharma supply chain

In this episode of the Frictionless Supply Chain, Beth Hayes, a consultant to pharmaceutical companies, joins host Rosemary Coates, executive director of the Reshoring Institute, to discuss the complexity of pharmaceutical supply chains. Pharmaceuticals and other medical products require unique compliance with FDA regulations and control. This complexity sets this industry's supply chains apart from most others. 

Listen today

 

Manufacturing of a finished product is typically outsourced if the drug is made in mass quantities, as is the case with off-the-shelf products such as Tylenol and Excedrin, which are made overseas. This introduces issues of oversight and regulatory adherence. Stringent requirements like the U.S. FDA Drug Supply Chain Security Act (DSCSA) require complex, full-batch traceability, making it difficult to quickly switch manufacturers or suppliers.

Other drugs, particularly personalized drug treatments, are made in small lots or even in a lot of one, making production of these life-saving products difficult to plan. Manufacturing must be precise, often includes controlled substances and sterilization processes, and all of this is carefully controlled by government regulations.

Raw materials as well as finished products may require carefully monitored cold-chain shipping and protection from contamination. Roughly 70% of the top-selling pharma products require temperature-controlled logistics, with about $35 billion lost annually due to temperature-controlled failures and improper handling.

Geopolitical and cybersecurity risks

We can easily imagine our dependence on China and India for drugs such as antibiotics. Geopolitics play an important role in securing the supply. Concentration of drug manufacturing in one country or region results in vulnerabilities caused by politics and policies, potentially threatening the supply of drugs to the U.S. or other countries which could be devastating to populations.

Cybersecurity is yet another risk in the global supply of drugs. Contamination of products or disruption of distribution through cyberattacks are possibilities.  While cybersecurity is a major concern in all industries, the pharmaceutical industry is particularly vulnerable.

These are not everyday supply chain challenges

Pharmaceutical industry supply chains and logistics are difficult, requiring skilled and experienced supply chain professionals to source, plan, produce, package, and distribute drugs. The overlay of government regulations adds a unique and additional layer of complexity. Geopolitics plays a critical intervening role. Hats off to our supply chain colleagues working in this challenging industry.

SC
MR